Out of jail, is the CRISPR-baby scandal scientist at it again?
By Natasha Mitchell,
ABC [feat. CGS' Katie Hasson]
| 03. 17. 2023
Chinese scientist Dr Jiankui He flouted the law and bioethics basics to create the world's first CRISPR gene edited babies. Now out of jail, he's on Twitter recruiting patients and raising funds for more trials, this time in adults not embryos. An unhelpful distraction or a cautionary lesson for the world's scientists? Dr Joy Zhang has an extraordinary insider view after a recent encounter with Dr He. Dr Katie Hasson is part of a global Coalition to Stop Designer Babies, and runs a Missing Voices initiative to diversify who gets a say about heritable genome editing.
Listen to the full episode at the link!
Guests:
Dr Joy Zhang
Founding director, Centre for Global Science and Epistemic Justice
University of Kent, UK
Co-author, The Elephant and the Dragon in Contemporary Life Sciences (Manchester University Press, 2022)
Dr Katie Hasson
Associate Director
Center for Genetics and Society, USA
Further information:
Looking Back into the Future: CRISPR and Social Values (University of Kent report from meeting with Dr He Jiankui in February 2023)
The Third International Summit on Human Gene Editing, London, 2023 (livestream videos via the...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...
